Dose daily

U.S. FDA Grants Accelerated Approval for Bayer’s Sevabertinib as First-Line Therapy in Advanced HER2-Mutant NSCLC Following 75% Response Rate

Bayer announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for sevabertinib, an oral, targeted HER2 tyrosine kinase inhibitor (TKI), as a first-line treatment for...

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...

Lupin’s Ankleshwar Plant Secures US FDA EIR

Global pharma major Lupin Limited (Lupin)  announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA)...

Wockhardt Achieves Milestone Approval for First-in-Class Antibiotic ZAYNICH®️

Wockhardt Ltd., a research-based global pharmaceutical and biotechnology company, announced that the Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorization for the import...

Anupam Rasayan is Preparing to Acquire 43% Stake in Bliss GVS Pharma for Around ₹1,369 Crore

Anupam Rasayan India the Gujarat based Specialty chemicals maker is all set to acquire 43.3 % stake in pharmaceutical formulations company Bliss GVS Pharma Ltd. According to reports Anupam Rasayan has already signed an agreement...

Lupin Secures ANDA Approval, Set to Enter the Chinese Market

Indian global pharma giant on 22 May, though a press release has announced that the company has received the China's National Medical Products Administration’s (NMPA) approval of Abbreviated New Drug Application (ANDA) for its Oseltamivir...

Alembic Receives USFDA Approval for Levothyroxine Sodium Tablets

Alembic Pharmaceuticals Limited  announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...

Commitment Towards Precise Diagnostic Services: Metropolis Healthcare Launches New Greenfield Laboratoryin Panjab

On 22nd May 2026, the Metropolis Healthcare, one of Indias leading diagnostics chain launches their new “Greenfield Laboratory” in Panjab’s Amritsar. The inauguration was graced by Dr. Anumeet Singh Grover, renowned gastroenterologist along with other renowned medical professionals across the country and...